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Abstract 
Background: The article reports on the cost-effectiveness of the proactive, integrated primary care program Finding 
and Follow-up of Frail older persons (FFF) compared with usual primary care for community-dwelling frail older persons 
in the Netherlands.
Methods: This study had a matched quasi-experimental design (pretest and posttest). The economic evaluation 
was performed from a healthcare perspective with a time horizon of 12 months. The target population consisted of 
community-dwelling frail older persons aged ≥ 75 years in the FFF intervention group (11 general practitioner (GP) 
practices) and in the control group receiving usual care (4 GP practices). The effectiveness measures for the cost-effec-
tiveness and cost-utility analyses were subjective well-being (Social Production Function Instrument for the Level of 
well-being short; SPF-ILs) and QALYs (EuroQol; EQ-5D-3L), respectively. Costs were assessed using resource use ques-
tionnaires. Differences in mean effectiveness between groups were assessed using univariate, multilevel and propen-
sity score matched analyses, with and without imputation of missing values. Differences in costs were assessed using 
Mann–Whitney U-tests and independent samples t-tests. Bootstrapping was performed, and predicted incremental 
cost-effectiveness ratios (ICERs) and incremental cost-utility ratios (ICURs) were depicted on cost-effectiveness planes.
Results: The various analyses showed slightly different results with respect to differences in estimated costs and 
effects. Multilevel analyses showed a small but significant difference between the groups for well-being, in favor of 
the control group. No significant differences between groups in terms of QALYs were found. Imputed data showed 
that mean total costs were significantly higher in the intervention group at follow-up.
Conclusion: Proactive, integrated care for community-dwelling frail older persons as provided in the FFF program is 
most likely not a cost-effective initiative, compared with usual primary care in the Netherlands, in terms of well-being 
and QALYs over a 12-month period.
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Background
This article reports on the cost-effectiveness of a proac-
tive, integrated primary care approach compared with 
usual primary care for community-dwelling frail older 
persons in the Netherlands. We evaluated the Find-
ing and Follow-up of Frail older persons (FFF) approach, 
which aims to maintain or improve older people’s well-
being and is implemented by part of the Dutch general 
practitioners (GPs). The FFF approach consists of proac-
tive identification of frail older persons in the community 
and subsequent multidisciplinary (including profession-
als with geriatric expertise) consultations and individual-
ized follow-up coordinated by case managers. Integrated 
care and support is widely acknowledged to be a key ini-
tiative in improving care and support for older persons 
[1]. In addition, integrated care approaches, like the FFF 
program, may help to maintain community-dwelling frail 
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older persons’ well-being [2]. Over the years, a shift has 
occurred from a disease-oriented care model toward a 
more proactive and integrated approach [3]. Traditional 
disease-specific care delivery approaches for frail older 
persons, who often have multiple conditions, do not meet 
these individuals’ comprehensive (healthcare) needs [4–
8]. Moreover, frailty has been associated with increased 
utilization of primary, hospital, and nursing home care 
[9, 10]. The provision of high-quality care and support to 
the growing number of frail older persons poses a chal-
lenge [11, 12], and the comprehensive (healthcare) needs 
of this population place a burden on healthcare resources 
[13]. Integrated care initiatives are assumed to improve 
quality of care and ultimately aim to enhance patient out-
comes while making efficient use of healthcare resources 
[14, 15]. Important elements of integrated care are: (i) a 
proactive approach that is coordinated effectively around 
a person’s health and social care needs; (ii) a patient-cen-
tered approach in which a person is involved in decision-
making and care processes, and the person’s needs are 
taken into consideration; (iii) an approach in which mul-
tiple interventions are delivered (simultaneously); and 
(iv) a multidisciplinary approach in which professionals 
from multiple disciplines are involved [3]. GPs are con-
sidered to be key actors in the implementation of prom-
ising initiatives targeting frail older persons [9]. Many 
integrated care initiatives have emerged and are imple-
mented in the primary healthcare sector, but evidence 
of their effectiveness and cost-effectiveness remains 
mixed [3, 16–21]. Integrated primary care programs for 
frail older persons have shown no effect on the majority 
of outcomes, and evidence for their cost-effectiveness is 
limited [16]. Although the FFF approach has been found 
to have positive effects on the quality of care as perceived 
by healthcare professionals [22], and to achieve improve-
ments in older persons’ perceived care quality and copro-
duction of care over time [23], its cost-effectiveness has 
yet to be investigated. Therefore, the aim of the present 
study was to evaluate the cost-effectiveness of the FFF 
approach in a population of community-dwelling frail 
older persons.
Methods
Design, setting and participants
This longitudinal evaluation study had a matched quasi-
experimental design with one pretest and one posttest 
(12-month follow-up period). The study was conducted 
in 15 GP practices located in the western part of North 
Brabant Province, the Netherlands, between 2014 and 
2017. The intervention group consisted of community-
dwelling frail persons aged 75 years and older who were 
registered at 11 GP practices that implemented the 
proactive, integrated primary care approach FFF. The 
control group consisted of community-dwelling frail 
older persons (≥ 75 years of age) who were registered at 
4 GP practices that delivered usual primary care. Writ-
ten informed consent to participate in the study was 
obtained from all participants. All participants in the 
intervention group were individually matched one-to-
one to participants in the control group based on sex 
(male/female), educational level (low/high), and frailty 
score. As shown in Fig.  1, each group consisted of 232 
frail older persons at baseline. At T1, 182 older per-
sons remained in the intervention group and 176 older 
persons remained in the control group (loss to follow-
up rates of 21.6% and 24.1% respectively). The medical 
research ethics committee of the Erasmus Medical Cen-
tre in Rotterdam, the Netherlands, concluded that the 
rules laid out in the Medical Research Involving Human 
Subjects Act did not apply (study protocol number 
MEC-2014-444). More details of the study design have 
been published elsewhere [24].
Usual primary care
Compared with the primary care systems in many coun-
tries in Europe, the Dutch primary care system is strongly 
developed. Many different (healthcare) providers, includ-
ing GPs, primary care psychologists and physiotherapists, 
are involved in primary care delivery in the Netherlands 
[25]. GPs have a central role in the healthcare sector and 
a strong gatekeeping function [26], implying that referral 
is generally necessary to access most hospital and special-
ist care [25, 27]. Each patient is registered at a GP prac-
tice of his or her choice, usually located in the person’s 
neighborhood. GPs are commonly patients’ first contact 
with the healthcare system, and most first encounters 
take place after the occurrence of a (medical) problem. 
In general, GPs in the Netherlands are considered to be 
non-interventionist, resulting in relatively low prescrip-
tion and referral rates. In comparison with GPs in other 
European countries, Dutch GPs provide a broad scope 
of (healthcare) services to their patients. Collaboration 
between GPs and (practice) nurses is common [25]. An 
example of a nurse-led service is the provision of dia-
betes management in primary care [27]. In the care for 
community-dwelling frail older persons, GPs can consult 
elderly care physicians with expertise in geriatric medi-
cine [28]. The primary care system lacks, however, suf-
ficient coordination and continuity (with specialist care) 
and is reactive and characterized by fragmentation [29]. 
Frail older persons in this study’s control group received 
usual care services provided by their GP practices and 
local health and community organizations. For a detailed 
description of care delivery and implemented inter-
ventions in control and intervention GP practices, see 
Vestjens, Cramm, and Nieboer [22].
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Intervention
Frail older persons in the intervention group received 
primary care according to the FFF approach. This 
approach combines several interrelated components (see 
Table 1) with the aim of providing high-quality proactive, 
integrated primary care for frail community-dwelling 
older persons. A decline of the well-being of commu-
nity-dwelling frail older persons may be expected over 
time [2]. Consequently, the aim of the FFF program is to 
maintain or improve frail older people’s well-being and 
protect against its deterioration. The FFF approach is 
implemented in GP practices and led by GPs. Commu-
nity-dwelling older patients registered at the GP practices 
are screened for frailty using the Tilburg Frailty Indica-
tor (TFI) [30] during a home visit by the practice nurse, 
homecare nurse or geriatric nurse. This 15-item ques-
tionnaire assesses frailty in the physical, psychological, 
and social domains. Scores range from 0 to 15, and per-
sons with scores ≥ 5 are identified as frail [30]. Persons 
with TFI scores < 5 can also be identified as frail based on 
additional examination by professionals. Problems and 
needs are reported in multiple domains according to the 
SFSPC-model, i.e., somatic (e.g., pain, fall risk), functional 
(e.g., limitations in activities of daily living like problems 
with eating or household activities), social (e.g., social 
network), psychological (e.g., fear, coping, depression), 
and communication (e.g., visual or hearing impairments). 
Outcomes of this in-home assessment are reported and 
discussed with the GPs and elderly care physicians, i.e., 
physicians in primary care with expertise in geriatric 
medicine [28]. Multidisciplinary primary care teams and 
collaboration among different disciplines in multiple FFF-
related activities are central to the FFF approach. Geri-
atric expertise is easily accessible by close involvement 
of elderly care physicians and geriatric nurses. Older 
persons’ (healthcare) needs are discussed in multidisci-
plinary consultation at least once a year. Individualized 
care plans include reported problems and (healthcare) 
needs, tailored (self-management) interventions, plans 
for multidisciplinary follow-up and evaluation. The care 
plan is discussed with the older person during a home 
visit by the practice nurse, homecare nurse or geriatric 
nurse. The care plan is then tailored to the person’s needs 
and wishes. Follow-up of older patients is arranged by a 
multidisciplinary team of (healthcare) professionals and 
an appointed case manager, who coordinates and evalu-
ates the process, and provides support in goal setting 
and self-management. Older patients’ medication use 
is examined at least annually by GPs, elderly care physi-
cians or pharmacists and discussed with the patients and 
their informal caregivers or relatives. Box 1 illustrates the 
application of the FFF approach. Further details on the 
components of the FFF approach have been published 
elsewhere [22, 24].
Older persons included in 
intervenon group at T0
n=232
Older persons in 
intervenon group at T1
n=182 (78.4%)
Lost to follow-up n=50 (21.6%)
Independently living persons
- Died (n=14)
- Too ill to parcipate (n=14)
- Refused (n=4)
Long-term care facility
- Died (n=4)
- Too ill to parcipate (n=7)
- Refused to parcipate (n=1)
Unreachable (n=5)
Other reasons (n=1)
Older persons included in 
control group at T0
n=232
Older persons in control 
group at T1
n=176 (75.9%)
Lost to follow-up n=56 (24.1%)
Independently living persons
- Died (n=13)
- Too ill to parcipate (n=17)
- Refused (n=11)
Long-term care facility
- Died (n=1)
- Too ill to parcipate (n=8)
- Refused to parcipate (n=1)
Unreachable (n=4)
Other reasons (n=1)
Fig. 1 Flowchart of study participation
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Box 1 A case of a frail older person participating in the FFF 
approach
Mr. Buys is 82  years old and has always lived in his 
parental home in the countryside near Roosendaal. 
His wife passed away 2 years ago and his two sons live 
and work in the capital city, Amsterdam. A diabetes 
check-up by his practice nurse raised alarm regarding 
Mr. Buys’ physical and social well-being. In response, 
the practice nurse screened Mr. Buys for frailty dur-
ing a home visit; his TFI score was 8. In addition, Mr. 
Buys reported problems in the somatic, functional, 
and social domains. It became apparent that Mr. Buys 
misses having people around him and experiences 
problems in his daily life due to fatigue and difficulty 
in walking. He explained to the practice nurse that he 
lacks contact with his social network. After discussion 
with the GP and elderly care physician, a preliminary 
individualized care plan was established and Mr. Buys’ 
case was discussed in multidisciplinary consultation. 
Based on Mr. Buys’ reported problems and needs, a 
physiotherapist, geriatric nurse, and social worker 
were included in the multidisciplinary team, along 
with the practice nurse, GP, and elderly care physician. 
The geriatric nurse was appointed as Mr. Buys’ case 
manager (responsible for, e.g., discussing the (self-
management) interventions that were proposed in the 
multidisciplinary consultation and adjusting the care 
plan to his wishes). The elderly care physician exam-
ined Mr. Buys’ medication use and arranged a home 
visit to evaluate his diabetes management. The physi-
otherapist visited Mr. Buys regularly to improve his 
physical functioning and to minimize fall risk through, 
e.g., walking and balance exercises. The case manager 
discussed several options to improve Mr. Buys’ social 
contact and independence. He decided to visit a day 
care center twice a week to be involved in meaningful 
activities and contact with older persons in his area of 
residence. The geriatric nurse contacted Mr. Buys (by 
home visit or telephone) and evaluated his follow-up 
regularly.
the difference in mean total costs adjusted for baseline 
costs between the intervention and control groups in 
the numerator and the difference in mean effectiveness 
adjusted for baseline effectiveness in the denominator.
Outcomes and measures
The primary outcome of the CUA was quality-adjusted 
life-years (QALYs). The validated EuroQol (EQ-5D-3L) 
was used as a preference-based health status meas-
ure to estimate utilities in the QALY measure [31, 32]. 
The descriptive system of the EQ-5D measures health-
related quality of life in five health dimensions (mobil-
ity, self-care, usual activities, pain/discomfort, and 
anxiety/depression) on a three-point scale (1 = no prob-
lems, 2 = some or moderate problems, 3 = severe prob-
lems), resulting in 243 distinct health states [31, 32]. 
The EQ-5D health states were transformed into util-
ity scores using the Dutch EQ-5D tariffs. Utilities based 
on the Dutch tariff range from − 0.33 to 1 (< 0 = health 
state considered worse than death, 0 = death or health 
state regarded to be equivalent to death, 1 = full health) 
[33]. For the CEA, the primary outcome was subjective 
well-being, measured with the validated short form of 
the Social Production Function Instrument for the Level 
of well-being (SPF-ILs) [34]. This 15-item instrument 
assesses whether five instrumental goals (comfort, stim-
ulation, status, behavioral confirmation, and affection) 
are met in order to optimize universal goals of social 
and physical well-being [2, 34–36]. Mean SPF-ILs scores 
range from 1 to 4, with higher scores indicating greater 
subjective well-being [34]. EQ-5D and SPF-ILs outcomes 
were measured among frail older patients in the inter-
vention and control groups at T0 and T1.
Healthcare utilization and costs
Total costs of intervention and control care at T0 and 
T1 were estimated as the summation of resources used 
multiplied by prices or valuations. Volumes of health-
care utilization were determined by the administration 
of resource use questionnaires during in-home inter-
views at T0 and T1. Frail older persons reported the 
types and frequencies (e.g., days of hospitalization or 
number of visits to the GP) of care they had received. 
To determine volumes of resource use, the following 
data were collected: numbers of GP consultations, out-
of-hours GP consultations (i.e., at home or in the care 
clinic on evenings/nights/weekends), admissions to 
hospital/nursing home/home for the elderly, and visits 
to the physiotherapist/exercise therapist/psychologist/
psychiatrist/social worker/medical specialist; and types 
of homecare service (i.e., household activities, personal 
care and nursing care at home), and elderly daycare 
Cost‑utility and cost‑effectiveness analyses
The economic evaluation of the FFF approach consisted 
of a cost-utility analysis (CUA) and a cost-effectiveness 
analysis (CEA) from a healthcare perspective with a time 
horizon of 12 months. Costs and effects were measured 
at baseline (T0) and 12 months (T1). Trained interview-
ers administered questionnaires during in-home inter-
views to collect data regarding healthcare utilization and 
outcomes. The incremental cost-utility ratio (ICUR) and 
the incremental cost-effectiveness ratio (ICER) represent 
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or daycare treatment received. We also included costs 
related to the purchase of assistive aids (e.g., wheel-
chair) and in-home modifications as patient-related 
costs. Intervention costs included all costs related to 
the FFF activities, i.e., selection of patients, proactive 
screening for frailty, provision of feedback information, 
multidisciplinary consultation, individualized care plan 
development, medication review, and follow-up of frail 
older persons (see Table  1). We estimated the average 
amount of time spent on intervention related activities 
per patient by (a combination of ) different healthcare 
professionals involved. Information for this estima-
tion was collected by the FFF project leader and was 
based on registers of the contact persons for GP prac-
tices, minutes from multidisciplinary consultations, and 
observations made during frailty screening. The health-
care professionals involved in FFF-related activities dif-
fered among GP practices and frail older patients, due 
to the compositions of the practice teams, (healthcare) 
disciplines with services accessible in the region, and 
tailoring of the FFF approach to the wishes and needs of 
individual patients. FFF follow-up involved healthcare 
utilization (e.g., consultation with the practice nurse or 
social worker). To avoid duplicate inclusion of costs, we 
included such service use in the healthcare costs, and 
not in the intervention costs. Only consultations with 
healthcare professionals that were not registered on the 
resource use questionnaires were included in the inter-
vention costs. Study-related activities and costs were 
excluded. We did not consider costs related to the train-
ing of involved healthcare professionals.
Healthcare resource volumes were valued using the 
Dutch manual for costing in healthcare [37]. Volumes of 
resource use were multiplied by standardized cost prices 
per unit of resource use (in euros) to estimate costs. 
Prices were inflated to 2015 (reference year) using the 
general consumer price index of 0.6% (Statistics Neth-
erlands). When standardized costs per unit of resource 
use were unavailable, we estimated costs using true eco-
nomic costs in the year 2015. To estimate costs related 
to out-of-hour GP consultations, we used the true eco-
nomic weighted mean costs for this service in western 
North Brabant Province provided by the Dutch Health-
care Authority. Average expenditures based on Internet 
sources and expenditures obtained in previous research 
using the same resource use questionnaire were used to 
value purchased assistive aids and in-home modifications 
[38]. Annual depreciation costs were calculated accord-
ing to the annuity method [37]. Intervention costs were 
based on the average amount of time invested per FFF 
element and hourly wages of the professionals involved, 
with proportional time investment applied when more 
than one professional was involved.
Missing data
Results are presented with and without imputation of 
missing values. Missing values were imputed according 
to the type of parameter (cost volume, utility, QALYs, 
SPF-ILs score), time point (T0, T1) and, for T1, reason 
for drop-out (see Fig. 1). Missing cost volumes at T0 were 
imputed with the mean cost volume of the specific ser-
vice for the intervention group or control group at T0. 
The imputation of QALYs at T0 depended on the num-
ber of missing EQ-5D domains. When only one EQ-5D 
domain score was missing, the EQ-5D utility score was 
imputed using the median utility score of other persons 
in the same (intervention or control) group who had the 
same scores on the non-missing EQ-5D domains. When 
no participant in the same group had the same scores or 
more than one domain was missing, the missing utility 
score was replaced with the median utility score for the 
respective group. The mean SPF-ILs score was calculated 
when at least 10 of the 15 items were reported. Missing 
values at T0 were replaced with the mean SPF-ILs score 
in the respective group at T0. Missing costs, utilities, 
QALYs and SPF-ILs scores for participants in the inter-
vention and control groups at T1 were imputed the same 
way as at T0. Missing costs and effects on T1 question-
naires of older persons that were lost to follow-up in the 
intervention group and control group between T0 and T1 
(n = 50 and n = 56 respectively; see Fig. 1) were imputed 
as follows. Based on registrations of case managers and 
GPs, we estimated the number of months that a person 
lived at home, lived in a nursing/elderly home, and the 
number of months lost due to mortality. For each older 
person that was lost to follow-up, missing costs at T1 
were imputed with the sum of (1) the number of months 
the person lived at home multiplied by the mean monthly 
healthcare costs (excluding the costs of nursing/elderly 
home admission) in the respective group at T1, and 
when applicable, (2) the number of months the person 
lived in a nursing/elderly home multiplied by monthly 
costs of nursing/elderly home admission, and (3) costs 
were set at zero from the month a participant died dur-
ing the follow-up period. For persons for whom nothing 
further was known (n = 11), we used the mean healthcare 
costs in the respective group at T1. Missing QALYs at T1 
were replaced with the sum of (1) the number of months 
a person lived at home multiplied by the median utility 
score at T1, and (2) the number of months a person lived 
in a nursing/elderly home multiplied by the utility score 
of 0.5 [39], and (3) a utility score of 0 was assigned from 
the month a person died. For persons for whom nothing 
further was known (n = 11), we used the QALYs in the 
respective group at T1. Finally, missing SPF-ILs values 
were imputed with the mean SPF-ILs group score at T1 
due to the lack of SPF-ILs norm values. Additional file 1: 
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Table S1 outlines the number of participants with miss-
ing data.
Statistical analyses
We assessed differences in baseline characteristics 
between the intervention and control groups using inde-
pendent samples t-tests (for continuous variables with 
approximately normal distributions) and Chi squared 
tests (for categorical variables). Unadjusted differences 
in mean SPF-ILs scores and QALYs between groups were 
assessed using independent samples t-tests. Unadjusted 
differences in mean SPF-ILs scores and QALYs over 
time within each group were assessed using paired sam-
ple t-tests. Furthermore, these univariate analyses were 
complemented with multilevel analyses (linear mixed-
effects models) to investigate effectiveness of the FFF 
approach. Multilevel models are considered appropriate 
for investigating relationships in data sets with continu-
ous dependent variables and a clustered structure of the 
data (persons within GP practices) [40]. A random inter-
cept was used on the level of the individual GP prac-
tices. Outcome estimates in the multilevel analyses were 
adjusted for baseline values of the respective outcome 
variable, background variables (i.e., age, sex, marital sta-
tus, educational level, frailty score and multimorbidity) 
and control/intervention group. We performed the mul-
tilevel models (with QALYs and well-being as outcome 
estimates) using data with and without imputation of 
missing values.
Volumes of healthcare utilization were presented as 
means (and corresponding standard deviations; SDs) per 
service use category. Differences in costs between groups 
were tested using Mann–Whitney U-tests (skewed data) 
and independent samples t-tests (for mean values). Dif-
ferences in costs over time within each group were 
assessed using related-samples Wilcoxon signed rank 
tests and paired sample t-tests.
Furthermore, propensity score matching was used to 
deal with potential different distributions of covariates 
between the intervention and control groups at baseline 
[41]. According to Indurkhya, Mitra, and Schrag [41], 
the propensity score is considered the probability that a 
person is assigned to the intervention group conditional 
on the person’s covariate information. For each individ-
ual person, the propensity to be part of the intervention 
group was estimated using a binary logistic regression 
model predicting assignment to the intervention group 
from baseline covariates. The covariates in the first logis-
tic regression model (Model 1) were age, sex, marital sta-
tus, educational level, frailty score, and multimorbidity. 
Next to these covariates, we also included baseline SPF-
ILs, QALYs and costs in the second logistic regression 
model (Model 2). We then compared observed outcomes 
between intervention and control groups conditional on 
the propensity matched scores [42].
We performed nonparametric bootstrapping (percen-
tile method) to generate 1500 samples from the origi-
nal sample of 232 matched pairs. Predicted ICERs and 
ICURs were depicted on cost-effectiveness planes to 
show uncertainty therein. A statistical significance level 
of 5% (two-sided) was used in the analyses. All statistical 
analyses were performed with IBM SPSS Statistics ver-
sion 24.
Results
Table  2 shows the background characteristics of the 
study population at baseline. In total, 72.4% of partici-
pants were female, 41.8% had a low educational level, 
and 94.4% were considered to be frail according to the 
TFI (mean TFI score, 7.38) in both groups. At baseline, 
compared with participants in the control group, older 
persons in the intervention group were significantly less 
often single (p < 0.05). No significant difference in mean 
age or the proportion of older persons with multimorbid-
ity was observed between the groups.
Table  3 shows the mean QALYs (with utilities based 
on the EQ-5D) and mean well-being scores (SPF-ILs) 
at T0 and T1 using the imputed dataset. Independent 
samples t-tests showed no statistically significant differ-
ences in QALYs between groups at T0 or T1 (univari-
ate analysis). Paired sample t-tests showed a statistically 
significant improvement in QALYs over time in the con-
trol group (∆0.05; p < 0.05), but not in the intervention 
group (∆0.04; p = 0.07). Without imputation of missing 
values, the data also showed a significant improvement 
in terms of QALYs in the intervention group over time 
(paired sample t-test, ∆0.05; p < 0.05). Well-being did 
not differ significantly at T0 or T1 between the control 
Table 2 Background characteristics of  older persons 
in the two study groups at baseline
Values are presented as mean (SD) or number (%)
TFI: Tilburg Frailty Indicator (range 0–15)
Independent samples t-tests or Chi squared tests
*p < 0.05 (two-tailed)
Care as usual 
(n = 232)
FFF approach 
(n = 232)
Characteristics
 Age 82.41 (5.16) 82.45 (5.44)
 Sex (female) 168 (72.4%) 168 (72.4%)
 Marital status (single) 160 (69.0%) 134 (57.8%)*
 Education (low) 97 (41.8%) 97 (41.8%)
 Frailty score (TFI) 7.38 (2.39) 7.38 (2.40)
 Frail (TFI score ≥ 5) 219 (94.4%) 219 (94.4%)
 Multimorbidity (≥ 2 conditions) 208 (89.7%) 215 (92.6%)
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and intervention groups, or over time in either group. 
Additional file 2: Table S2 displays the mean QALYs and 
SPF-ILs results of the univariate analyses based on data 
without imputation of missing values. Analyses based on 
data of matched participants, i.e., pairs with complete 
data, yielded comparable findings; independent samples 
t-tests showed no significant differences in mean QALYs 
and mean well-being scores between the groups at T0 
and T1 (see Additional file 3: Tables S4–S7).
Multilevel analyses of SPF-ILs scores adjusted for back-
ground variables and baseline values showed a small but 
significant difference between the intervention group 
and control group for well-being at follow-up, in favor of 
the control group (− 0.09 (with imputation) and − 0.10 
(without imputation)). No significant differences between 
the groups in terms of QALYs were observed (− 0.03 
(with imputation) and − 0.02 (without imputation)) 
(Additional file 4: Tables S8–S11). Regression analyses to 
investigate multivariable relationships among the varia-
bles yielded comparable results as the multilevel analyses 
(details not shown). The multilevel analyses were redone 
for the propensity score matched group which showed a 
significant difference between the groups for well-being 
in favor of the control group [(− 0.09 (with imputation) 
and − 0.10 (without imputation)]. We found no sig-
nificant differences in QALYs between the intervention 
group and control group [− 0.03 (with imputation) and 
− 0.02 (without imputation)]. For details see Additional 
file 5: Tables S12–S19.
For the imputed dataset, mean total costs were 7717 
euros (SD, 9824 euros) in the control group and 9182 
euros (SD, 11,754 euros) in the intervention group at 
baseline (independent samples t-test, p = 0.15; Mann–
Whitney U-test, U = 28,618.50, t = 1.18, p = 0.24; 
Table  4). At 12  months, mean total costs were signifi-
cantly higher in the intervention group (11,659 [SD, 
14,600] euros; including intervention costs) than in the 
control group (8902 [SD, 11,227] euros) (independent 
samples t-test, p < 0.05; Table 5). In addition, differences 
in the median total costs at follow-up were statisti-
cally significant (Mann–Whitney U-test, U = 29,952.00, 
t = 2.11, p < 0.05). The mean total costs increased signifi-
cantly over time in the intervention group (paired sam-
ple t-test, p < 0.05), but not in the control group (paired 
sample t-test, p = 0.14). The difference in median costs 
between T0 and T1 was significant in the interven-
tion group (related-samples Wilcoxon signed rank test, 
t = 3.18, p < 0.05) and in the control group (related-sam-
ples Wilcoxon signed rank test, t = 2.34, p < 0.05). Based 
on the data without imputation of missing values, no sta-
tistically significant differences in total costs between the 
control and intervention groups were found at baseline 
(independent samples t-test, p = 0.15; Mann–Whitney 
U-test, U = 17,165.50, t = 0.60, p = 0.55) and 12  months 
(independent samples t-test, p = 0.09; Mann–Whitney 
U-test, U = 14,375.50, t = 1.09, p = 0.28). For details see 
Additional file 2: Table S3. In addition, univariate analy-
ses for the propensity score matched group yielded com-
parable results; for the imputed dataset mean total costs 
were significantly higher in the intervention group com-
pared with the control group at 12  months. Based on 
data without imputation of missing values, no signifi-
cant differences in mean total costs between groups were 
observed at both time points. Univariate analyses based 
on data of matched participants, i.e., pairs with complete 
data, showed no significant difference in mean total costs 
between the groups at baseline and follow-up. See Addi-
tional file 3: Tables S4–S7.
Using the imputed dataset, estimated differences in 
effectiveness and costs were both in favor of usual care, 
producing an ICER of − 14,788 euros per SPF-ILs point 
and an ICUR of − 126,711 euros per QALY, indicat-
ing the FFF approach is inferior in both approaches. In 
Fig. 2 (cost-effectiveness plane for costs versus effects in 
terms of well-being; SPF-ILs), 0.9% of all bootstrapped 
ICERs appear in the southeast quadrant (dominance; 
FFF approach is more effective and less costly), 78.9% 
appear in the northwest quadrant (inferiority; FFF 
intervention is more expensive and less effective), 1.5% 
appear in the northeast quadrant (FFF intervention 
is more effective, but also more expensive) and 18.7% 
appear in the southwest quadrant (FFF intervention is 
less costly, but also less effective). The probability that 
the FFF approach is cost-effective ranges between 0.9% 
and 21.1%, depending on the cost-effectiveness ratio 
Table 3 Well-being and  QALYs at  baseline (T0) and   
12 months (T1)
Values are presented as mean (SD)
SPF-ILs: Social Production Function Instrument for the Level of well-being short 
(range 1–4); EQ-5D-3L: five-dimensional three-level EuroQol (range for utilities, 
− 0.33 to 1)
Data from univariate analyses after imputation of missing values
Paired sample t-tests or independent samples t-tests
*p < 0.05 (two-tailed)
a  Significant improvement in QALYs in the control group over time based on 
paired data
Care as usual  
(n = 232)
FFF approach 
(n = 232)
Outcome measures
 Well-being (SPF-ILs)
  T0 2.62 (0.50) 2.63 (0.49)
  T1 2.67 (0.49) 2.59 (0.46)
 QALYs (utilities based on EQ-5D-3L)
  T0 0.66 (0.24) 0.63 (0.26)
  T1 0.71 (0.20)*,a 0.67 (0.24)
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a decision maker could apply for policy decisions. In 
Fig.  3  (cost-effectiveness plane for costs versus effects 
in terms of QALYs), 9.0% of bootstrapped ICURs are 
located in the southeast quadrant, 54.4% appear in the 
northwest quadrant, 26.1% are located in the north-
east quadrant, and 10.5% are located in the southeast 
quadrant. The probability that the FFF approach is cost-
effective ranges between 9.0% and 45.6%, depending on 
the cost-effectiveness ratio applied. 
Although different analyses (e.g., univariate, multilevel, 
and propensity score matched analyses, with and without 
imputation) showed slightly different results with respect 
to estimated costs and effects, the data suggest that the 
FFF approach is most likely not cost-effective compared 
with usual primary care in the Netherlands in terms of 
well-being and QALYs over a 12 month-period, irrespec-
tive of analytical approach and method of handling miss-
ing values.
Discussion
The results of our economic evaluation indicate that pro-
active, integrated care for community-dwelling frail older 
persons as provided in the FFF program is most likely 
not a cost-effective initiative compared with usual pri-
mary care in the Netherlands, in terms of well-being and 
QALYs over a 12-month period. Our results are in line 
with outcomes of other studies investigating the cost-
effectiveness of integrated care for frail older persons 
in the primary care setting in the Netherlands [43]. The 
comparability of integrated care programs and evaluation 
studies is limited due to differences in study populations, 
interventions and outcomes [16].
One explanation for the lack of effect may be the con-
ceivably small difference between the FFF approach and 
usual primary care services in the Netherlands. There are 
indications that reforms in the primary care system in the 
Netherlands resulted in developments in the control GP 
Table 4 Healthcare use and costs (in euros) per patient per year in the intervention and control groups at baseline
a Means (SDs) were calculated including persons without healthcare utilization
b Mean total costs calculated after imputation of missing healthcare costs
Care as usual (n = 232) FFF approach (n = 232)
Mean  usea (SD) Total costs (SD) in € Mean  usea (SD) Total costs (SD) in €
Healthcare
 Hospital (days) 1.87 (4.90) 893.66 (2327.38) 1.76 (5.53) 845.29 (2634.78)
 Consultations with the GP 3.51 (2.93) 116.43 (94.87) 3.80 (3.90) 126.25 (126.85)
 Consultations out-of-hours GP 0.23 (0.67) 22.12 (63.01) 0.28 (0.70) 26.74 (65.77)
 Professional homecare (hours per week)
  Household activities (homecare or  
personal budget)
1.58 (1.77) 1780.95 (1967.73) 1.67 (1.76) 1887.95 (1955.74)
  Household activities (private) 0.52 (1.20) 582.04 (1320.02) 0.59 (1.80) 664.86 (1988.32)
  Personal care 0.88 (1.89) 2315.93 (4766.32) 1.04 (2.22) 2731.71 (5583.19)
  Nursing care 0.28 (1.48) 1085.97 (5512.92) 0.29 (1.57) 1108.73 (5757.76)
 Care home (weeks) 0.11 (0.96) 129.16 (1128.74) 0.13 (1.37) 151.08 (1613.16)
 Nursing home (weeks) 0.07 (0.71) 77.49 (838.43) 0.14 (1.09) 162.03 (1285.98)
 Elderly day care (days per week) 0.03 (0.27) 213.34 (1889.62) 0.09 (0.49) 606.89 (3397.51)
 Day care treatment (days per week) 0.0 (0.0) 0.0 (0.0) 0.03 (0.23) 375.02 (3269.36)
 Physiotherapist (consultations) 6.77 (15.34) 224.68 (506.64) 6.75 (16.22) 224.06 (537.29)
 Exercise therapist (consultations) 0.28 (1.94) 9.41 (65.98) 0.72 (5.77) 24.75 (195.62)
 Medical specialist (consultations) 2.71 (4.58) 248.02 (408.44) 2.33 (3.36) 213.07 (301.12)
 Social worker (sessions) 0.09 (1.03) 6.05 (66.81) 0.02 (0.21) 1.14 (13.56)
 Psychologist or psychiatrist (sessions) 0.06 (0.47) 3.99 (29.69) 0.25 (1.30) 15.96 (83.10)
Assistive aids and in-home modifications
 Wheelchair 0.03 (0.18) 1.63 (8.65) 0.04 (0.20) 2.04 (9.63)
 Alarm system 0.06 (0.25) 1.61 (6.14) 0.06 (0.23) 1.40 (5.74)
 Wheeled walker 0.09 (0.29) 1.86 (5.91) 0.13 (0.34) 2.66 (6.91)
 Stairlift 0.0 (0.0) 0.0 (0.0) 0.02 (0.15) 6.71 (45.30)
 Adjusted doorsteps 0.004 (0.07) 0.08 (1.23) 0.02 (0.13) 0.32 (2.44)
 Adjusted bathroom 0.09 (0.29) 3.31 (10.24) 0.11 (0.31) 3.76 (10.84)
Mean total  costsb 7717.72 (9824.92) 9182.42 (11,754.75)
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practices to improve their care delivery. Although these 
practices did not provide care and support according to 
the FFF approach, several control GP practices imple-
mented interventions, such as systematic follow-up of 
older adults and multidisciplinary consultation, during 
the study period [22]. In addition, the lack of effectiveness 
of complex interventions may be partly due to failure to 
(fully) implement the programs as intended [44]. Indeed, 
we have found suboptimal implementation of interven-
tion components in GP practices organizing care accord-
ing to the FFF approach [22]. Most interventions, and 
especially complex care programs like the FFF approach, 
require extensive time and effort to achieve full imple-
mentation [45, 46]. We noted differences among inter-
vention GP practices with respect to the implementation 
and execution of the FFF program, including differences 
in the selection of older persons for proactive screening, 
the (number of ) professionals involved in screening pro-
cedures, the organization of multidisciplinary consulta-
tions (e.g., frequency, number of patients discussed, (type 
of ) professionals involved), and the organization of long-
term follow-up of frail older persons [22]. These differ-
ences may obscure the added value of the FFF approach 
in terms of QALYs and well-being. Analyses based on 
matched participants of intervention GP practices with a 
high degree of implementation of (FFF-related) interven-
tions (i.e., practices that implemented more interventions 
than average) [22], showed that the mean SPF-ILs score 
was higher, indicating greater subjective well-being, com-
pared with participants in other intervention GP prac-
tices (Additional file  6: Tables S20–S23). Therefore, the 
degree of implementation may have an effect on effec-
tiveness of complex interventions like the FFF approach. 
For a detailed description of implemented (FFF-related) 
Table 5 Healthcare use and costs (in euros) per patient per year in the intervention and control groups at 12 months
a Means (SDs) were calculated including persons without healthcare utilization
b Mean total costs calculated after imputation of missing healthcare costs including persons lost to follow-up between T0 and T1 (n = 50 in the intervention group 
and n = 56 in the control group)
Care as usual (n = 176) FFF approach (n = 182)
Mean  usea (SD) Total costs (SD) in € Mean  usea (SD) Total costs (SD) in €
Healthcare
 Hospital (days) 2.66 (6.92) 1275.14 (3305.59) 2.14 (9.55) 1026.89 (4546.80)
 Consultations with the GP 3.57 (3.41) 118.61 (111.78) 3.83 (3.44) 127.14 (113.30)
 Consultations out-of-hours GP 0.25 (0.88) 24.23 (82.89) 0.22 (0.60) 21.05 (56.49)
 Professional homecare (hours per week)
  Household activities (homecare or  
personal budget)
1.16 (1.50) 1302.25 (1671.23) 1.58 (1.63) 1772.57 (1816.37)
  Household activities (private) 0.76 (1.37) 850.15 (1520.05) 0.46 (1.21) 520.28 (1344.72)
  Personal care 0.92 (1.91) 2393.81 (4928.75) 1.37 (2.83) 3574.16 (7270.45)
  Nursing care 0.11 (0.50) 432.95 (1871.74) 0.31 (1.33) 1182.55 (4976.57)
 Care home (weeks) 0.20 (1.27) 236.61 (1496.48) 0.17 (1.18) 197.18 (1387.62)
 Nursing home (weeks) 0.09 (0.81) 102.85 (962.21) 0.28 (2.15) 330.47 (2524.32)
 Elderly day care (days per week) 0.05 (0.37) 358.45 (2624.88) 0.05 (0.33) 350.48 (2361.89)
 Day care treatment (days per week) 0.02 (0.23) 246.11 (3264.99) 0.04 (0.30) 641.70 (4244.80)
 Physiotherapist (consultations) 6.01 (10.89) 199.39 (361.68) 8.64 (18.07) 286.74 (594.85)
 Exercise therapist (consultations) 0.31 (3.48) 10.75 (118.69) 1.36 (9.63) 46.36 (327.42)
 Medical specialist (consultations) 2.65 (4.07) 242.74 (371.38) 2.25 (3.17) 227.60 (287.96)
 Social worker (sessions) 0.06 (0.45) 3.72 (29.43) 0.45 (4.06) 29.59 (263.51)
 Psychologist or psychiatrist (sessions) 0.04 (0.38) 2.58 (24.20) 0.22 (1.20) 13.95 (76.65)
Assistive aids and in-home modifications
 Wheelchair 0.01 (0.11) 0.54 (5.03) 0.03 (0.18) 1.57 (8.47)
 Alarm system 0.06 (0.23) 1.41 (5.78) 0.08 (0.28) 2.06 (6.87)
 Wheeled walker 0.07 (0.25) 1.40 (5.20) 0.09 (0.29) 1.93 (6.00)
 Stairlift 0.01 (0.11) 3.54 (33.09) 0.02 (0.13) 5.16 (39.74)
 Adjusted doorsteps 0.02 (0.15) 0.42 (2.79) 0.0 (0.0) 0.0 (0.0)
 Adjusted bathroom 0.09 (0.28) 2.97 (9.76) 0.03 (0.16) 0.96 (5.72)
Mean total  costsb 8902.06 (11,227.42) 11,426.21 (14,600.79)
Mean total intervention costs n/a 233
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interventions in the GP practices see Vestjens, Cramm 
and Nieboer [22]. Even with optimal implementation of 
such interventions, clinically meaningful improvement in 
outcomes is not guaranteed in the short term [45]. The 
length of the study period, being 12  months, may have 
been too short to detect improvements in older per-
sons’ outcomes [20]. Especially in the short term, varia-
tions in costs and effects can be expected [47]. Patterns 
of healthcare utilization show, for example, a substan-
tial increase in primary and hospital care utilization in 
frail older persons [9]. Consequently, the identification 
of frailty and introduction of interventions to postpone 
or prevent a decline into worse health states [48] may 
result in higher healthcare costs in the short term, but 
might reduce use of more expensive healthcare services 
and adverse outcomes in the long term [9]. Another 
Fig. 2 Cost-effectiveness plane for costs (in euros) versus effects (SPF-ILs; range 1–4) adjusted for baseline differences; data after imputation of 
missing values
Fig. 3 Cost-effectiveness plane for costs (in euros) versus effects (QALYs; range − 0.33 to 1) adjusted for baseline differences; data after imputation 
of missing values
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explanation might be related to the heterogeneity of the 
population of older persons considered to be frail. No 
consensus has been reached about the conceptualiza-
tion and measurement of frailty in older persons. Major 
approaches include the frailty phenotype, which focuses 
on physical aspects of frailty [49, 50], and a multidimen-
sional approach to frailty including, for example, physi-
cal, social, and psychological factors [51]. Although we 
used a multidimensional approach to assess frailty in 
this study, Looman and colleagues [52] showed that dis-
tinction among domains of frailty does not fully capture 
its complexity. The TFI [30], which we used to measure 
(the degree of ) frailty in older persons, does not discern 
among types of underlying problems in these domains or 
weigh different domains [52]. Researchers have suggested 
that the heterogeneity of frailty should be taken into 
account in the evaluation of integrated care programs 
[52], especially to better understand how interventions 
can be optimally aligned with different well-being needs 
of frail older persons [2].
Strengths and limitations
One strength of this study is that we measured the sub-
jective well-being of community-dwelling frail older 
persons along with health-related quality of life. QALY 
measures in economic evaluations are based predomi-
nantly on aspects of health-related quality of life alone. 
Care programs for older persons may also aim to improve 
non-health related domains of quality of life. Thus, the 
sole use of health-related quality of life measures in eco-
nomic evaluations may not be appropriate, as it may not 
capture broader benefits of such interventions beyond 
health [53]. Consequently, Makai and colleagues [53] 
recommended the inclusion of well-being measures with 
health measures like the EQ-5D in economic evaluations 
of care programs for older persons. We did so, although 
the different perspectives did not lead to different recom-
mendations regarding the preference of the FFF interven-
tion. Another strength of our study is the quality of the 
data gathered. We used dedicated, trained interviewers 
who collected the data in face-to-face interviews during 
home visits. All interviewers lived in the western North 
Brabant Province, assuring a cultural fit, and had back-
grounds in healthcare. Moreover, we used a detailed 
resource use questionnaire covering a wide range of 
healthcare categories to assess healthcare utilization at 
the individual level. We included care disciplines that 
are frequently not included in studies, such as paramedi-
cal (e.g., physiotherapy) and psychological care, which 
may have increased content validity. Our study also 
has several potential limitations. First, we used a quasi-
experimental design, which is more susceptible to bias 
due to the absence of randomization [54]. To increase 
comparability of the intervention and control groups, 
we used one-to-one matching based on key covariables. 
Despite this effort, the control group contained sig-
nificantly more single persons than did the intervention 
group. Moreover, we noted indications (based on inter-
views with healthcare professionals and (project) manag-
ers) of a strong motivation to organize care and support 
for the elderly population in some control GP practices. 
Professionals in these practices may have perceived that 
the FFF program would not add value to their usual care 
practices and were therefore perhaps especially eager to 
participate in the control group. Second, recall bias might 
have occurred due to the retrospective assessment of ser-
vice use in the preceding 12  months. Under-reporting 
and over-reporting of effects have been found in previous 
research in which health service utilization was assessed 
retrospectively [55]. Unfortunately, we were not able to 
include administrative or registry data to complement 
the reported healthcare service use. Nonetheless, given 
the same data collection procedure in both groups, we 
have no indication that recall bias varied significantly 
between the intervention and control groups. Third, 
mean standard costs of the FFF program were estimated, 
instead of assessing intervention costs for individual par-
ticipants. We attempted to avoid duplicate inclusion of 
costs by including service use related to the follow-up 
of older patients in the FFF context only in healthcare 
costs, and not in intervention costs. The implementation 
and execution of (elements of ) the FFF approach differed 
among intervention GP practices [22]. However, results 
of sensitivity analyses in which intervention costs were 
varied to test the robustness of the estimated ICER and 
ICUR did not affect the overall recommendation regard-
ing the preference of the FFF program. Fourth, despite 
recommendations [37], we were unable to collect data 
on informal care due to practical considerations. The 
impact of informal care costs on the mean total costs in 
the intervention and control groups remains unknown, 
although we found no indication (based on interviews 
with healthcare professionals, (project) managers, and 
frail older persons) of unequal distribution of infor-
mal care costs between groups. In addition, we did not 
account for medication costs in either group or interven-
tion training and implementation costs in the FFF group. 
We have noted no indication that medication use differed 
between groups.
Conclusions
Our study findings add to the current unconvincing 
body of evidence with respect to the cost-effectiveness 
of integrated primary care aimed at community-dwelling 
frail older persons. Future economic evaluations should 
use sufficiently long follow-up periods to assess durable 
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costs and effects, adopt a societal perspective, and take 
into account the degree of implementation and the tar-
get population. Continued effort is required to unravel 
the black box of integrated care and find (cost-)effective 
(components of ) programs for community-dwelling frail 
older persons.
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